Key result
Insulin reduces macrophage cholesterol biosynthesis ~81% in diabetic mice by modulating SREBP-1 expression.
Why the study?
Does insulin reduce macrophage foam cell formation and cholesterol biosynthesis in diabetic models?
Population
Diabetic mice and in vitro glucose-enriched macrophages
Comparison
Insulin injection and insulin incubation vs Age-matched untreated diabetic mice and…
Design
Preclinical
Authors
Loading...
Insulin's suppression of diabetic macrophage foam cell formation is hypothesis-generating; leaves open translation to human atheroprotection.
Does insulin reduce macrophage foam cell formation and cholesterol biosynthesis in diabetic models?
Insulin inhibits diabetes-mediated macrophage foam cell formation and cholesterol synthesis by modulating SREBP-1 expression and maturation, providing insights into atherogenesis in diabetes.
Kaplan et al. (2008) studied Diabetes and atherosclerosis. Insulin vs. Untreated diabetic mice and high glucose without insulin was evaluated on Macrophage cholesterol biosynthesis. Insulin treatment of diabetic mice significantly reduced macrophage cholesterol biosynthesis by 81% compared to untreated diabetic mice by modulating SREBP-1 expression.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: